B
Britta Velten
Researcher at European Bioinformatics Institute
Publications - 23
Citations - 1731
Britta Velten is an academic researcher from European Bioinformatics Institute. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 9, co-authored 18 publications receiving 799 citations. Previous affiliations of Britta Velten include German Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Multi-Omics Factor Analysis—a framework for unsupervised integration of multi-omics data sets
Ricard Argelaguet,Britta Velten,Damien Arnol,Sascha Dietrich,Thorsten Zenz,Thorsten Zenz,Thorsten Zenz,John C. Marioni,John C. Marioni,John C. Marioni,Florian Buettner,Wolfgang Huber,Oliver Stegle +12 more
TL;DR: Multi‐Omics Factor Analysis (MOFA) infers a set of (hidden) factors that capture biological and technical sources of variability that disentangles axes of heterogeneity that are shared across multiple modalities and those specific to individual data modalities.
Journal ArticleDOI
Gene expression across mammalian organ development
Margarida Cardoso-Moreira,Margarida Cardoso-Moreira,Jean Halbert,Delphine Valloton,Britta Velten,C. T. Chen,Yi Shao,Angélica Liechti,Kelly Ascencao,Coralie Rummel,Svetlana Ovchinnikova,Pavel V. Mazin,Pavel V. Mazin,Ioannis Xenarios,Keith Harshman,Matthew Mort,David Neil Cooper,Carmen Sandi,Michael J. Soares,Michael J. Soares,Paula G. Ferreira,Sandra Afonso,Miguel Carneiro,James M. A. Turner,John L. VandeBerg,Amir Fallahshahroudi,Per Jensen,R. Behr,Steven Lisgo,Susan Lindsay,Philipp Khaitovich,Philipp Khaitovich,Philipp Khaitovich,Wolfgang Huber,Julie C. Baker,Simon Anders,Yong Zhang,Henrik Kaessmann +37 more
TL;DR: It is found that the breadth of gene expression and the extent of purifying selection gradually decrease during development, whereas the amount of positive selection and expression of new genes increase during development.
Journal ArticleDOI
MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data
Ricard Argelaguet,Damien Arnol,Danila Bredikhin,Yonatan Deloro,Britta Velten,Britta Velten,John C. Marioni,John C. Marioni,John C. Marioni,Oliver Stegle,Oliver Stegle +10 more
TL;DR: This work presents Multi-Omics Factor Analysis v2 (MOFA+), a statistical framework for the comprehensive and scalable integration of single-cell multi-modal data that reconstructs a low-dimensional representation of the data using computationally efficient variational inference and supports flexible sparsity constraints.
Posted ContentDOI
Multi-Omics factor analysis - a framework for unsupervised integration of multi-omic data sets
Ricard Argelaguet,Britta Velten,Damien Arnol,Sascha Dietrich,Thorsten Zenz,John C. Marioni,Wolfgang Huber,Florian Buettner,Oliver Stegle +8 more
TL;DR: Multi-Omics Factor Analysis (MOFA), a computational method for discovering the principal sources of variation in multi-omic datasets, infers a set of (hidden) factors that capture biological and technical sources of variability and disentangles axes of heterogeneity.
Journal ArticleDOI
Drug-perturbation-based stratification of blood cancer
Sascha Dietrich,Małgorzata Oleś,Junyan Lu,Leopold Sellner,Simon Anders,Britta Velten,Bian Wu,Jennifer Hüllein,Michelle da Silva Liberio,Tatjana Walther,Lena Wagner,Sophie Rabe,Sophie Rabe,Sonja Ghidelli-Disse,Marcus Bantscheff,Andrzej K. Oleś,Mikolaj Slabicki,Andreas Mock,Christopher C. Oakes,Christopher C. Oakes,Shihui Wang,Sina Oppermann,Marina Lukas,Vladislav Kim,Martin Sill,Axel Benner,Anna Jauch,Lesley-Ann Sutton,Emma Young,Richard Rosenquist,Xiyang Liu,Alexander Jethwa,Kwang Seok Lee,Joe Lewis,Kerstin Putzker,Christoph Lutz,Davide Rossi,Andriy Mokhir,Thomas Oellerich,Thomas Oellerich,Katja Zirlik,Marco Herling,Florence Nguyen-Khac,Christoph Plass,Christoph Plass,Emma I. Andersson,Satu Mustjoki,Christof von Kalle,Anthony D. Ho,Manfred Hensel,Jan Dürig,Ingo Ringshausen,Marc Zapatka,Wolfgang Huber,Wolfgang Huber,Thorsten Zenz +55 more
TL;DR: This study overcomes the perception that most mutations do not influence drug response of cancer, and points to an updated approach to understanding tumor biology, with implications for biomarker discovery and cancer care.